Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Gastrointestinal 1

Conditions

Barrett Esophagus 2Zollinger-Ellison Syndrome 1Xerostomia 1Stomach Ulcer 1Stomach Neoplasms 1Oropharyngeal Neoplasms 1Mucositis 1Inflammation 1Helicobacter Infections 1Heartburn 1Head and Neck Neoplasms 1Gastroesophageal Reflux 1Gastritis, Atrophic 1Esophagitis, Peptic 1

Interventions

Radiotherapy 8Radiation 4Low-Level Light Therapy 4Cisplatin 3Amifostine 3Acupuncture Therapy 3Surveys and Questionnaires 2Surgical Procedures, Operative 2Standard of Care 2Saliva, Artificial 2Pilocarpine 2Oral Hygiene 2Iodine-131 2Chewing Gum 2pegfilgrastim 1ginger extract 1citric acid, deuterium oxide solution 1Xylitol 1Transcutaneous Electric Nerve Stimulation 1Smell 1Selenomethionine 1Respiration 1Paclitaxel 1Mouthwashes 1Lansoprazole 1Hypnosis 1Health Education, Dental 1Granulocyte Colony-Stimulating Factor 1Genetic Engineering 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Xerostomia × Dexlansoprazole × Clear all
NCT00928161 2012-09-07

Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy

M.D. Anderson Cancer Center

Phase NA Withdrawn
GastrointestinalHead & NeckOther

Gastroesophageal Reflux, Head and Neck Neoplasms, Heartburn, Oropharyngeal Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡